Vir Bio (VIR) reveals 24-week post-end-of-treatment data from a mid-stage trial for its Hep B therapy developed with Xencor ...

Get insights into Vir Biotechnology's Q1 2025 earnings call, including ECLIPSE Phase III trial progress, oncology updates, and financial highlights.

Discover an awarding winning abstract from EASL 2025 that has called for more person-centred hepatitis screening. Learn more.

Background Hepatitis B virus (HBV) is a common cause of viral hepatitis with significant health complications including cirrhosis and hepatocellular carcinoma. Assays for hepatitis B surface ...

An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV) in a mid-stage trial, setting up a phase 3 assessment next year to see if it could offer a ...

GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...

Researchers in India evaluated 1387 adults with asymptomatic hepatitis B virus (HBV) infection to determine the correlation between liver-enzyme elevations and histologic disease. Presumably ...

The best 4K gaming monitor has all the bells and whistles an enthusiast could ever want or need. The best 4K gaming monitor can make way more than games look great. It's a big upgrade to any ...

Fast becoming mainstays of gamers and creative pros, 4K monitors are falling in price—but getting more complicated to buy. Here's how to shop for an ultra-high-definition (UHD) display ...

Hepatitis D is a type of viral hepatitis that affects around 48 million people worldwide. It is less common than other types of hepatitis that you might be more familiar with. Hepatitis D is thought ...

Fortunately, there are many great gaming monitors available today, including those offering ultra-high-refresh 1080p, zippy 1440p options, high-fidelity 4K, and a slew of ultrawide panels.

Objective Better knowledge of hepatitis B virus (HBV) infection prevalence at the national level can help to implement pertinent strategies to address HBV related burden. The aim was to estimate the ...